Literature DB >> 10371375

Deletion polymorphism of the angiotensin converting enzyme gene is associated with an increase in left ventricular mass in men with type 2 diabetes mellitus.

R O Estacio1, B W Jeffers, E P Havranek, D Krick, M Raynolds, R W Schrier.   

Abstract

Previous studies evaluating the angiotensin converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism have revealed that expression of the DD genotype is associated with an increase in myocardial infarction, cardiomyopathy, and left ventricular (LV) mass in nondiabetic patients. In the present study, a cross-sectional analysis was performed to evaluate the potential relationship between the ACE I/D genotypes and the LV mass index in 289 non-insulin-dependent diabetes mellitus (NIDDM) subjects without known coronary artery disease. Two dimensional directed M-mode echocardiograms along with selected patient characteristics were obtained from the study population. The distribution of the I/D polymorphism was as follows: 63 were II (22%), 137 were ID (47%), and 89 were DD (31%). Univariately, the DD genotype was associated with an increase in LV mass in men but not in women. When subjected to a multiple regression model that included age, systolic blood pressure, duration of diabetes, duration of hypertension, presence of the black race, and the presence of the DD genotype, the DD genotype was independently associated with an increase in the LV mass index with a parameter estimate of 10.5 g/m2 (95% CI = 3.9, 17.0; P < .002) in the male subjects. Thus, in this NIDDM study population, male patients with the DD genotype are independently associated with an increased LV mass.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10371375     DOI: 10.1016/s0895-7061(99)00013-8

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  5 in total

Review 1.  The ACE gene and human performance: 12 years on.

Authors:  Zudin Puthucheary; James R A Skipworth; Jai Rawal; Mike Loosemore; Ken Van Someren; Hugh E Montgomery
Journal:  Sports Med       Date:  2011-06-01       Impact factor: 11.136

Review 2.  Genetic contributions to left ventricular hypertrophy.

Authors:  D K Arnett
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 5.369

Review 3.  Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease.

Authors:  Tevfik Ecder; Robert W Schrier
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

4.  Association of ACE gene D polymorphism with left ventricular hypertrophy in patients with diastolic heart failure: a case-control study.

Authors:  Ehsan Bahramali; Mona Rajabi; Javad Jamshidi; Seyyed Mohammad Mousavi; Mehrdad Zarghami; Alireza Manafi; Negar Firouzabadi
Journal:  BMJ Open       Date:  2016-02-09       Impact factor: 2.692

5.  Genetic variants predicting left ventricular hypertrophy in a diabetic population: a Go-DARTS study including meta-analysis.

Authors:  Helen M Parry; Louise A Donnelly; Natalie Van Zuydam; Alexander Sf Doney; Douglas Hj Elder; Andrew D Morris; Alan D Struthers; Colin Na Palmer; Chim C Lang
Journal:  Cardiovasc Diabetol       Date:  2013-07-23       Impact factor: 9.951

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.